Liposomal nanotherapy for treatment of atherosclerosis : passive versus active targeting
In spite of the success of current therapies and preventive strategies in reducing cardiovascular risk, cardiovascular diseases (CVD) continue to be the leading cause of death globally. Inflammation is the underlying pathological process of atherosclerosis, the major cause of most CVD, but has not b...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis-Doctor of Philosophy |
| Language: | English |
| Published: |
Nanyang Technological University
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/137197 |